The amiodarone--class I agent combination increases refractoriness, conduction, and the number of electrophysiologic studies. But does it increase survival rate?-Reference-Cited by-同舟云学术

The amiodarone--class I agent combination increases refractoriness, conduction, and the number of electrophysiologic studies. But does it increase survival rate?

Published:1991-07 Issue:1 Volume:84 Page:429-431
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Nademanee K

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.84.1.429

Reference23 articles.

1. Advances in Antiarrhythmic Therapy

2. A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

3. Outpatient Antiarrhythmic Drug Use From 1970 Through 1986

4. Minardo JD Heger JJ Miles WM Zipes DP Prystowsky EN: Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic therapy. NEnglJMed 1988;319:257-262

5. Use of antiarrhythmic drugs in patients with heart failure: Clinical efficacy, hemodynamic results, and relation to survival;Wilson JR;Circulation,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiarrhythmic Agents;Drug Safety;2000

2. Arzneimittelkombinationen mit Antiarrhythmika;Der Internist;1998-04-06

3. Effects of Sotalol on His-Purkinje Conduction and Refractoriness in Humans;Journal of Cardiovascular Pharmacology and Therapeutics;1996-01

4. Amiodarone and post-MI patients.;Circulation;1993-08

5. Refractory ventricular fibrillation in the electrophysiology laboratory: A nightmare from which we can awaken;Journal of the American College of Cardiology;1991-11